
Len May
Len May, MSC, is a global authority in personalized medicine, renowned for his expertise in medicinal cannabis and the endocannabinoid system. As CEO and co-founder of EndoDNA, Len revolutionizes wellness with patented DNA-based technology that deciphers genotypes for tailored health solutions. Under his visionary leadership, EndoDNA boasts the world’s largest real-world efficacy database, cementing its role as a leader in precision wellness.
With over 25 years of experience and three successful company exits, Len integrates genomics and epigenetics to optimize health outcomes. A holder of a Master’s in Medical Cannabis, he contributes to clinical trials, peer-reviewed journals, and public policy, advancing safe, evidence-based practices.
Len’s influence spans academia, industry, and global platforms.